Molecular formula: C₂₁-H₁₈-F₃-NO₃-S₂

Molar Mass: 453,498 g/mol

PubChem (CID): 9803963

Purity (HPLC): 98,6%

Serving Size: 1 Capsule

Servings Per Container: 30/60

Amount Per Serving: GW501516 - 10 mg

Cardarine is a selective agonist (activator) of the PPAR receptor and belongs to SPPARMs group. Agonists PPAR plays an important role in the treatment of cardiometabolic disorders due to obesity and complications associated with it. Clinical studies of the drug have proved it's high efficiency in the process of oxidation of fats and their further splitting. The process does not break metabolism, but rather stabilizes it. The drug does not cause weakness or decrease the sugar level in blood.

The effect of the drug is aimed at accelerating the process of lipolysis in the organism, thereby accelerating the process of splitting the fat molecules, and transforming them to free energy. Cardarine impacts on the metabolic pathways, that are activated by exercises and increases endurance, when performing the prolonged exercises. In addition, this drug has reducing properties that contribute to rapid recovery and reduces the recovery term from any scratches or injured muscles.

Cardarine has a potent anti-catabolic impact associated with the stimulation of the muscle fibers to use the fat as a main source of energy, but not as a self-absorption as a result of the lack of calories. In addition, it should be noted, that the drug effectively burns fat tissue without any physical activities.

The results of Cardarine usage:

• Reduces fat deposits.
• Increases stamina and performance.
• Increases the amount of energy consumed by the muscle tissue.
• Increases muscle prominence.
• Increases strength.
• Accelerates the recovery of an organism.
• Health improvement.

Cardarine doesn't produce any side effects and doesn't promote damage to the liver cells.

For research purposes only.